IFRX Stock Summary and Trading Ideas (Inflarx N.V. | NASDAQ:IFRX)

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Inflarx N.V. trades on the NASDAQ stock market under the symbol IFRX.

As of August 14, 2026, IFRX stock price climbed to $2.04 with 1,442,981 million shares trading.

IFRX has a beta of 3.25, meaning it tends to be more sensitive to market movements. IFRX has a correlation of 0.14 to the broad based SPY ETF.

IFRX has a market cap of $300.48 million. This is considered a Small Cap stock.

Last quarter Inflarx N.V. reported $0 in Revenue and -$.10 earnings per share. This fell short of revenue expectation by $-10,000 and missed earnings estimates by -$.02.

In the last 3 years, IFRX traded as high as $4.30 and as low as $.71.

The top ETF exchange traded funds that IFRX belongs to (by Net Assets): QQQS.

IFRX has outperformed the market in the last year with a price return of +146.6% while the SPY ETF gained +21.5%. However, in the short term, IFRX had mixed performance relative to the market. It has underperformed in the last 3 months, returning -14.3% vs +4.0% return in SPY. But in the last 2 weeks, IFRX shares have fared better than the market returning +20.0% compared to SPY +3.9%.

IFRX support price is $1.92 and resistance is $2.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IFRX shares will trade within this expected range on the day.